Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

1.

The translocator protein radioligand 18F-DPA-714 monitors antitumor effect of erufosine in a rat 9L intracranial glioma model.

Awde AR, Boisgard R, Thézé B, Dubois A, Zheng J, Dollé F, Jacobs AH, Tavitian B, Winkeler A.

J Nucl Med. 2013 Dec;54(12):2125-31. doi: 10.2967/jnumed.112.118794. Epub 2013 Nov 8.

2.

Analysis of the growth dynamics of angiogenesis-dependent and -independent experimental glioblastomas by multimodal small-animal PET and MRI.

Viel T, Talasila KM, Monfared P, Wang J, Jikeli JF, Waerzeggers Y, Neumaier B, Backes H, Brekka N, Thorsen F, Stieber D, Niclou SP, Winkeler A, Tavitian B, Hoehn M, Bjerkvig R, Miletic H, Jacobs AH.

J Nucl Med. 2012 Jul;53(7):1135-45. doi: 10.2967/jnumed.111.101659. Epub 2012 Jun 11.

3.

Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications.

Waerzeggers Y, Ullrich RT, Monfared P, Viel T, Weckesser M, Stummer W, Schober O, Winkeler A, Jacobs AH.

Br J Radiol. 2011 Dec;84 Spec No 2:S179-95. doi: 10.1259/bjr/76389842. Review.

4.

Specific biomarkers of receptors, pathways of inhibition and targeted therapies: pre-clinical developments.

Waerzeggers Y, Monfared P, Viel T, Faust A, Kopka K, Schäfers M, Tavitian B, Winkeler A, Jacobs A.

Br J Radiol. 2011 Dec;84 Spec No 2:S168-78. doi: 10.1259/bjr/66405626. Review.

5.

Noninvasive molecular imaging of neuroinflammation.

Jacobs AH, Tavitian B; INMiND consortium.

J Cereb Blood Flow Metab. 2012 Jul;32(7):1393-415. doi: 10.1038/jcbfm.2012.53. Epub 2012 May 2. Review.

6.

The translocator protein ligand [¹⁸F]DPA-714 images glioma and activated microglia in vivo.

Winkeler A, Boisgard R, Awde AR, Dubois A, Thézé B, Zheng J, Ciobanu L, Dollé F, Viel T, Jacobs AH, Tavitian B.

Eur J Nucl Med Mol Imaging. 2012 May;39(5):811-23. doi: 10.1007/s00259-011-2041-4. Epub 2012 Jan 21.

7.

Imaging herpes simplex virus type 1 amplicon vector-mediated gene expression in human glioma spheroids.

Kaestle C, Winkeler A, Richter R, Sauer H, Hescheler J, Fraefel C, Wartenberg M, Jacobs AH.

Mol Imaging. 2011 Jun;10(3):197-205. doi: 10.2310/7290.2010.00036. Epub 2011 Mar 1.

PMID:
21443839
8.

Imaging bone morphogenetic protein 7 induced cell cycle arrest in experimental gliomas.

Klose A, Waerzeggers Y, Monfared P, Vukicevic S, Kaijzel EL, Winkeler A, Wickenhauser C, Löwik CW, Jacobs AH.

Neoplasia. 2011 Mar;13(3):276-85.

9.

[18F]FLT PET for non-invasive monitoring of early response to gene therapy in experimental gliomas.

Rueger MA, Ameli M, Li H, Winkeler A, Rueckriem B, Vollmar S, Galldiks N, Hesselmann V, Fraefel C, Wienhard K, Heiss WD, Jacobs AH.

Mol Imaging Biol. 2011 Jun;13(3):547-57. doi: 10.1007/s11307-010-0361-6.

PMID:
20563754
10.

Mouse models in neurological disorders: applications of non-invasive imaging.

Waerzeggers Y, Monfared P, Viel T, Winkeler A, Jacobs AH.

Biochim Biophys Acta. 2010 Oct;1802(10):819-39. doi: 10.1016/j.bbadis.2010.04.009. Epub 2010 May 13. Review.

11.

Radioisotopic imaging of neuroinflammation.

Winkeler A, Boisgard R, Martin A, Tavitian B.

J Nucl Med. 2010 Jan;51(1):1-4. doi: 10.2967/jnumed.109.065680. Epub 2009 Dec 15. Review.

12.

Methods to monitor gene therapy with molecular imaging.

Waerzeggers Y, Monfared P, Viel T, Winkeler A, Voges J, Jacobs AH.

Methods. 2009 Jun;48(2):146-60. doi: 10.1016/j.ymeth.2009.03.007. Epub 2009 Mar 24. Review.

PMID:
19318125
13.

Early detection of erlotinib treatment response in NSCLC by 3'-deoxy-3'-[F]-fluoro-L-thymidine ([F]FLT) positron emission tomography (PET).

Ullrich RT, Zander T, Neumaier B, Koker M, Shimamura T, Waerzeggers Y, Borgman CL, Tawadros S, Li H, Sos ML, Backes H, Shapiro GI, Wolf J, Jacobs AH, Thomas RK, Winkeler A.

PLoS One. 2008;3(12):e3908. doi: 10.1371/journal.pone.0003908. Epub 2008 Dec 12.

14.

Multimodal imaging of neural progenitor cell fate in rodents.

Waerzeggers Y, Klein M, Miletic H, Himmelreich U, Li H, Monfared P, Herrlinger U, Hoehn M, Coenen HH, Weller M, Winkeler A, Jacobs AH.

Mol Imaging. 2008 Mar-Apr;7(2):77-91.

PMID:
18706290
15.

Noninvasive assessment of E2F-1-mediated transcriptional regulation in vivo.

Monfared P, Winkeler A, Klein M, Li H, Klose A, Hoesel M, Waerzeggers Y, Korsching S, Jacobs AH.

Cancer Res. 2008 Jul 15;68(14):5932-40. doi: 10.1158/0008-5472.CAN-07-6373.

16.

Molecular imaging-guided gene therapy of gliomas.

Rueger MA, Winkeler A, Thomas AV, Kracht LW, Jacobs AH.

Handb Exp Pharmacol. 2008;(185 Pt 2):341-59. doi: 10.1007/978-3-540-77496-9_15. Review.

PMID:
18626610
17.

Imaging noradrenergic influence on amyloid pathology in mouse models of Alzheimer's disease.

Winkeler A, Waerzeggers Y, Klose A, Monfared P, Thomas AV, Schubert M, Heneka MT, Jacobs AH.

Eur J Nucl Med Mol Imaging. 2008 Mar;35 Suppl 1:S107-13. doi: 10.1007/s00259-007-0710-0. Review.

18.

In vivo evaluation of the uptake of [(123)I]FIAU, [(123)I]IVFRU and [(123)I]IVFAU by normal mouse brain: potential for noninvasive assessment of HSV-1 thymidine kinase gene expression in gliomas.

Li HF, Winkeler A, Moharram S, Knaus EE, Dittmar K, Stöckle M, Heiss WD, Wiebe LI, Jacobs AH.

Nucleosides Nucleotides Nucleic Acids. 2008 Jan;27(1):57-66. doi: 10.1080/15257770701571933. Erratum in: Nucleosides Nucleotides Nucleic Acids. 2008 Aug;27(8):1009.. Jacob, A J [corrected to Jacobs A H].

PMID:
18188770
19.

Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma.

Miletic H, Fischer YH, Giroglou T, Rueger MA, Winkeler A, Li H, Himmelreich U, Stenzel W, Jacobs AH, von Laer D.

Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6761-8.

20.

Switching on the lights for gene therapy.

Winkeler A, Sena-Esteves M, Paulis LE, Li H, Waerzeggers Y, Rückriem B, Himmelreich U, Klein M, Monfared P, Rueger MA, Heneka M, Vollmar S, Hoehn M, Fraefel C, Graf R, Wienhard K, Heiss WD, Jacobs AH.

PLoS One. 2007 Jun 13;2(6):e528.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk